My name is Henry and I’m a senior biochemistry major, class of 2023.
In the US alone, an estimated 3 million adults (1.3% of the population) are diagnosed with ulcerative colitis or Crohn’s, and the effects on peoples’ lives can be debilitating. Mesalamine is an anti-inflammatory drug used to treat ulcerative colitis and Crohn’s disease. My project aims to improve mesalamine’s performance through cocrystallization while elucidating the crystal structures formed between the drug and its coformers.
When I’m not working on my project, I love going on hiking, cooking, going to coffee shops, and exploring new places (which I’ll then drag my friends to later).